Open house Pharmaceutical Rebate Agreements for the active ingredient Denosumab, trade name Xgeva, ATC M05BX04
Open house Arzneimittelrabattverträge zum Wirkstoff Denosumab, Handelsname Xgeva, ATC M05BX04
Germany
Contract
BuyerAOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
TypeSupplies
Estimated valuevalue not published
Published18 May 2025
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| axicorp Pharma B.V. · EC Den Haag | 32 | 2017–2022 |
| Aliud Pharma GmbH · Laichingen | 28 | 2017–2023 |
| Abacus Medicine A/S · Kopenhagen | 27 | 2018–2023 |
| kohlpharma GmbH · Merzig | 26 | 2017–2023 |
| EurimPharm Arzneimittel GmbH · Saaldorf-Surheim | 25 | 2019–2023 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2019358
2020364
2021382
2022407
2023494
2024460
2025742
2026360
Who knows the rhythm prepares instead of reacting.
254
days until the deadline — Friday 30 April at 21:59
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →